文献速递甲状腺疾病

甲状腺激素替代治疗不充分与更差的住院结局相关

Suboptimal Thyroid Hormone Replacement Is Associated With Worse Hospital Outcomes.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

基于美国商业理赔数据库的回顾性队列研究,纳入43478例住院前有促甲状腺激素(TSH)检测的患者,按TSH水平分组。住院前TSH>10.00 mIU/L者较平衡对照的住院时间延长1.2天(95%CI 1.1-1.3;P=.003),30天再入院风险高49%(RR 1.49;95%CI 1.20-1.85;P<.001),90天再入院率高43%(RR 1.43;95%CI 1.21-1.67;P<.001);TSH正常者院内死亡风险降低(RR 0.46;95%CI 0.27-0.79;P=.004)。作者认为甲状腺功能减退治疗不充分与更差的住院结局相关。

要点

  • 住院前TSH>10.00 mIU/L者住院时间较平衡对照延长1.2天(95%CI 1.1-1.3;P=.003)。
  • 住院前TSH>10.00 mIU/L者30天再入院风险较平衡对照高49%(RR 1.49;95%CI 1.20-1.85;P<.001)。
  • 住院前TSH正常者院内死亡风险较平衡对照降低(RR 0.46;95%CI 0.27-0.79;P=.004)。

核心结论

  • 结果提示甲状腺功能减退治疗不充分与更差的住院结局相关,包括住院时间延长和再入院率升高。

研究设计与样本

  • 回顾性队列研究,使用倾向评分精细分层法平衡协变量,数据来自美国大型商业理赔数据库(2008年1月1日至2015年12月31日)。
  • 纳入64岁及以下、住院前有促甲状腺激素(TSH)检测结果的患者,最终研究人群43478例,其中8873例诊断为甲状腺功能减退。
  • 暴露为临床甲状腺功能减退,按住院前TSH水平分为4个亚组:低(TSH<0.40 mIU/L)、正常(TSH 0.40-4.50 mIU/L)、中间(TSH 4.51-10.00 mIU/L)、高(TSH>10.00 mIU/L)。
  • 协变量包括年龄、性别、美国地区、入院类型、入院年份和合并症。
  • 主要结局指标包括住院时间(LOS)、院内死亡和再入院结局。

主要发现

  • 住院前TSH>10.00 mIU/L者较平衡对照住院时间延长1.2天(95%CI 1.1-1.3;P=.003)。
  • 住院前TSH>10.00 mIU/L者较平衡对照30天再入院风险高49%(RR 1.49;95%CI 1.20-1.85;P<.001)。
  • 住院前TSH>10.00 mIU/L者较平衡对照90天再入院率高43%(RR 1.43;95%CI 1.21-1.67;P<.001)。
  • 住院前TSH正常者较平衡对照院内死亡风险降低(RR 0.46;95%CI 0.27-0.79;P=.004)。
  • 住院前TSH正常者较平衡对照90天再入院风险降低(RR 0.92;95%CI 0.85-0.99;P=.02)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Many patients with hypothyroidism receive suboptimal treatment that may affect hospital outcomes. OBJECTIVE: This work aimed to identify differences in hospital outcomes between patients with and without hypothyroidism. METHODS: A retrospective cohort study, using the propensity score-based fine stratification method to balance covariates, was conducted using a large, US-based, commercial claims database from January 1, 2008 to December 31, 2015. Participants included patients aged 64 years and younger who had a thyrotropin (TSH) level collected before a hospital admission. Covariates included age, sex, US region, type of admission, year of admission, and comorbidities. Exposure included clinical hypothyroidism, which was divided into 4 subgroups based on prehospitalization TSH level: low (TSH < 0.40 mIU/L), normal (TSH 0.40-4.50 mIU/L), intermediate (TSH 4.51-10.00 mIU/L), and high (TSH > 10.00 mIU/L). MAIN OUTCOME MEASURES INCLUDED: length of stay (LOS), in-hospital mortality, and readmission outcomes. RESULTS: A total of 43 478 patients were included in the final study population, of whom 8873 had a diagnosis of hypothyroidism. Those with a high prehospitalization TSH level had an LOS that was 1.2 days longer (95% CI, 1.1-1.3; P = .003), a 49% higher risk of 30-day readmission (relative risk [RR] 1.49; 95% CI, 1.20-1.85; P < .001), and a 43% higher rate of 90-day readmission (RR 1.43; 95% CI, 1.21-1.67; P < .001) compared to balanced controls. Patients with normal TSH levels exhibited decreased risk of in-hospital mortality (RR 0.46; 95% CI, 0.27-0.79; P = .004) and 90-day readmission (RR 0.92; 95% CI, 0.85-0.99; P = .02). CONCLUSION: The results suggest suboptimal treatment of hypothyroidism is associated with worse hospital outcomes, including longer LOS and higher rate of readmission.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ettleson MD, Bianco AC, Wan W, et al. Suboptimal Thyroid Hormone Replacement Is Associated With Worse Hospital Outcomes. J Clin Endocrinol Metab. 2022. PMID: 35472082. doi:10.1210/clinem/dgac215

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。